Credit: Provepharm Inc Phenylephrine hydrochloride is indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia. The recall ...
A drug used to bring a person’s blood pressure back up after anesthesia is being recalled because it may not be sterile. Sagent Pharmaceuticals announced its nationwide recall of three lots of ...
A potential packaging glitch that could compromise sterility has triggered a recall at Sagent Pharmaceuticals. The drugmaker issued a voluntary recall of three lots of injectable phenylephrine ...
One lot of Phenylephrine hydrochloride Injection, USP, 10 mg/mL is being recalled due to particulate matter found in a vial. Provepharm announced on Jan. 24, 2025 that it has voluntarily recalled one ...
Paragon BioTeck announced it has received FDA approval for Phenylephrine HCl Ophthalmic Solution, USP, to dilate the pupil. Phenylephrine HCl is an alpha-1 receptor agonist which acts as a potent ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the United States of Phenylephrine Hydrochloride Injection, USP. Fresenius Kabi Phenylephrine ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Do not use if you have ever had an allergic reaction to phenylephrine ...
On Thursday the Food and Drug Administration announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in over-the-counter monograph drug products for the ...
Xellia’s US-based Hospital Sales Force Will Immediately Begin Promoting Biorphen in Collaboration with Eton Agreement Significantly Expands Biorphen Commercial Footprint and Provides Access to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results